CRISP3 and Sjogren syndrome: In humans, CRISP3 was described in several tissues and differences in its expression are associated with different pathologies such as prostate cancer (Kosari et al., 2002; Bjartell et al., 2007; Noh et al., 2016), breast cancer (Tang et al., 2020), Sjögren’s syndrome (Laine et al., 2007), varicocele (Belardin et al., 2019), prostatitis and endometriosis (Grande et al., 2017), among others.